Matches in SemOpenAlex for { <https://semopenalex.org/work/W2275451520> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2275451520 endingPage "9" @default.
- W2275451520 startingPage "607" @default.
- W2275451520 abstract "Posttransplant erythrocytosis is a well-known complication of renal transplant. It is a persistently elevated hematocrit level equal to or greater than 51%, or a hemoglobin level equal to or greater than 16 g/L, or both, in the absence of other causes.We retrospectively reviewed this complication in patients who had received a renal transplant at our center between January 1991 and December 2005.Of 1655 renal transplant recipients, 159 patients (9.6%; 154 men, 5 women; mean age, 42 +/- 9 years) developed posttransplant erythrocytosis. The mean follow-up was 96 +/- 4 months. Posttransplant erythrocytosis appeared at an average of 8.2 +/- 5 months after transplant (range, 3-40 months) and lasted an average of 10.3 +/- 3 months (range, 7-35 months). In all 159 patients, the immunosuppressive medication regimen included prednisolone; in 144, cyclosporine was used, and in 108 patients, azathioprine was used, while in another group of patients, the latter 2 were changed to mycophenolate mofetil (n=38) and tacrolimus (n=13). Twenty-four patients (15%) were treated with phlebotomies, while 29 patients (18.2%) were given angiotensin-converting enzyme inhibitors. One hundred six patients were left untreated including 92 patients (57.9%) who received prophylactic anti-platelet medications. Remission of posttransplant erythrocytosis was seen in all treated and untreated patients. No thromboembolic complications occurred. Only 9 patients (5.7%) developed chronic allograft nephropathy during follow-up.Our findings suggest that posttransplant erythrocytosis is a benign condition affecting males more than females, usually manifesting in the first year after transplant. Remission of posttransplant erythrocytosis can be seen in all patients; however, some patients may require treatment with phlebotomy or angiotensin-converting enzyme inhibitors. Posttransplant erythrocytosis has no adverse effects on renal graft function." @default.
- W2275451520 created "2016-06-24" @default.
- W2275451520 creator A5005493730 @default.
- W2275451520 creator A5022181547 @default.
- W2275451520 creator A5047834114 @default.
- W2275451520 creator A5053530222 @default.
- W2275451520 creator A5071741708 @default.
- W2275451520 creator A5088908310 @default.
- W2275451520 date "2007-06-01" @default.
- W2275451520 modified "2023-09-26" @default.
- W2275451520 title "Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia." @default.
- W2275451520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17617052" @default.
- W2275451520 hasPublicationYear "2007" @default.
- W2275451520 type Work @default.
- W2275451520 sameAs 2275451520 @default.
- W2275451520 citedByCount "1" @default.
- W2275451520 crossrefType "journal-article" @default.
- W2275451520 hasAuthorship W2275451520A5005493730 @default.
- W2275451520 hasAuthorship W2275451520A5022181547 @default.
- W2275451520 hasAuthorship W2275451520A5047834114 @default.
- W2275451520 hasAuthorship W2275451520A5053530222 @default.
- W2275451520 hasAuthorship W2275451520A5071741708 @default.
- W2275451520 hasAuthorship W2275451520A5088908310 @default.
- W2275451520 hasConcept C126322002 @default.
- W2275451520 hasConcept C141071460 @default.
- W2275451520 hasConcept C2776715498 @default.
- W2275451520 hasConcept C2776760755 @default.
- W2275451520 hasConcept C2777357209 @default.
- W2275451520 hasConcept C2779134260 @default.
- W2275451520 hasConcept C2779458710 @default.
- W2275451520 hasConcept C2780303639 @default.
- W2275451520 hasConcept C2780959883 @default.
- W2275451520 hasConcept C2909675724 @default.
- W2275451520 hasConcept C2911091166 @default.
- W2275451520 hasConcept C71924100 @default.
- W2275451520 hasConcept C81182388 @default.
- W2275451520 hasConcept C90924648 @default.
- W2275451520 hasConceptScore W2275451520C126322002 @default.
- W2275451520 hasConceptScore W2275451520C141071460 @default.
- W2275451520 hasConceptScore W2275451520C2776715498 @default.
- W2275451520 hasConceptScore W2275451520C2776760755 @default.
- W2275451520 hasConceptScore W2275451520C2777357209 @default.
- W2275451520 hasConceptScore W2275451520C2779134260 @default.
- W2275451520 hasConceptScore W2275451520C2779458710 @default.
- W2275451520 hasConceptScore W2275451520C2780303639 @default.
- W2275451520 hasConceptScore W2275451520C2780959883 @default.
- W2275451520 hasConceptScore W2275451520C2909675724 @default.
- W2275451520 hasConceptScore W2275451520C2911091166 @default.
- W2275451520 hasConceptScore W2275451520C71924100 @default.
- W2275451520 hasConceptScore W2275451520C81182388 @default.
- W2275451520 hasConceptScore W2275451520C90924648 @default.
- W2275451520 hasIssue "1" @default.
- W2275451520 hasLocation W22754515201 @default.
- W2275451520 hasOpenAccess W2275451520 @default.
- W2275451520 hasPrimaryLocation W22754515201 @default.
- W2275451520 hasRelatedWork W1974011841 @default.
- W2275451520 hasRelatedWork W1995484973 @default.
- W2275451520 hasRelatedWork W2018346252 @default.
- W2275451520 hasRelatedWork W2057936131 @default.
- W2275451520 hasRelatedWork W2069659290 @default.
- W2275451520 hasRelatedWork W2077303210 @default.
- W2275451520 hasRelatedWork W2093877097 @default.
- W2275451520 hasRelatedWork W2275451520 @default.
- W2275451520 hasRelatedWork W2427942379 @default.
- W2275451520 hasRelatedWork W2912234104 @default.
- W2275451520 hasVolume "5" @default.
- W2275451520 isParatext "false" @default.
- W2275451520 isRetracted "false" @default.
- W2275451520 magId "2275451520" @default.
- W2275451520 workType "article" @default.